On March 28, 2024, Axiom Health appointed two new leaders to enhance their capabilities and support the company’s growth trajectory. Russell “Rusty” Lewis was named Chief Executive Officer (CEO) and Jim Best was appointed Chief Commercial Officer (CCO). These appointments reflect the company’s commitment to delivering exceptional value in the medical device market.

Jim Hinrichs, Chairman of the Board, expressed excitement about the new appointments, highlighting the strategic vision of Russell Lewis and the customer-focused approach of Jim Best. The company is confident that these leadership additions will support their commitment to delivering exceptional value in the medical device market.

Russell Lewis brings extensive healthcare leadership experience to his role as CEO at Axiom Health. He has held key positions in organizations like McKesson, Amerisource Bergen, and Vizient, where he focused on driving innovation in healthcare technology. His expertise will be crucial in guiding Axiom Health’s growth trajectory and ensuring that clients receive top-notch data analytics solutions.

Jim Best joins Axiom Health with over 20 years of experience in the healthcare industry. He has held sales and marketing leadership positions at companies like Stryker, Integra Lifesciences, TriMed, and Komodo Health. His deep understanding of the challenges faced by medical device sales and marketing teams will be valuable in enhancing client success initiatives at Axiom Health.

Axiom Health is dedicated to empowering sales and marketing teams in the medical device industry with data-driven insights that drive informed decision-making and lead to better outcomes. The company’s analytics platform provides in-depth data that helps organizations optimize their strategies and stimulate growth. For more information about Axiom Health or their new appointments, please contact their Media Relations Department at [email protected] or visit their website at www.axiomhealth.com.